HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

NCT05166239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Portal Vein Thrombosis

Interventions

PROCEDURE: HAIC
DRUG: Lenvatinib 1
DRUG: PD-1 Inhibitors
DRUG: Lenvatinib 2
DRUG: PD-1 inhibitors 2

Sponsor

Peking University